• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIACASSIST INC. TANDEMLUNG OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIACASSIST INC. TANDEMLUNG OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 5160-0000
Device Problem Obstruction of Flow (2423)
Patient Problem Hypoxia (1918)
Event Date 08/09/2019
Event Type  Injury  
Event Description
Livanova received report of worsening thrombus noted at the level of tandelung oxygenator.The device was exchanged without complication.Post device exchange, initiation of full vent support was required and patient became hypoxic with hd compromise.In addition, chattering and decreased flow were noted.Pump speed was decreased and fluid bolus was given.No adverse outcome of the patient was reported.
 
Manufacturer Narrative
Cardiacassist inc.Manufactures the tandemlung oxygenator.The incident occurred in (b)(6).A medical assessment on the reported event has been conducted.The outcome of the assessment revealed that most likely the patient was ecmo dependent and is typical to have hypoxia episode in case of oxygenator replacement.In addition, as per medical assessment, chattering may have been due to the cannula and this behavior can be expected and can be anticipated.Moreover, in case of clotting formation, the entire circuit should have been replaced and not the oxygenator only.If any additional information pertinent to the reported event is received, it will be provided in a supplemental report.
 
Manufacturer Narrative
H10: the serial number of the device was not provided, thus dhr review could not be performed.The event occurred on ards patient with 175 act value on day before the event occurred.As per tandemlung oxygenator's instruction for use the effect of anticoagulants (e.G.Heparin) is required to be checked at regular intervals by measuring the activated clotting time (act) and the act should not fall below 450 sec.Taking into account the available information, it is unlikely that the device had malfunctioned and the reported event is most likely associated to patient/procedure factors such as anticoagulation theraphy.
 
Event Description
See initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TANDEMLUNG OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
CARDIACASSIST INC.
620 alpha drive
pittsburgh PA 15238
Manufacturer (Section G)
CARDIACASSIST INC.
620 alpha drive
pittsburgh PA 15238
Manufacturer Contact
enrico greco
620 alpha drive
pittsburgh, PA 15238
MDR Report Key12878114
MDR Text Key281275261
Report Number2531527-2021-00047
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153295
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 11/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number5160-0000
Device Catalogue Number5160-0000
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/28/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-